XTAMPZA ER
Severe pain
MarketedLifecycle Management
Key Facts
About Collegium Pharmaceutical
Collegium Pharmaceutical is a publicly traded, commercial-stage biopharmaceutical company with a strategic focus on pain management and neuropsychiatry. The company has established itself through a disciplined strategy of portfolio diversification, specializing in abuse-deterrent formulations and the acquisition/commercialization of differentiated medicines. Under new leadership, Collegium is executing on a growth trajectory, aiming to strengthen its position in ADHD and expand its impact through a commitment to science, corporate responsibility, and robust commercial execution.
View full company profileTherapeutic Areas
Other Severe pain Drugs
| Drug | Company | Phase |
|---|---|---|
| Envelta | Virpax Pharmaceuticals | Preclinical |
| Recivit® (Fentanyl) | Ethypharm | Approved |
| NUCYNTА / NUCIENTА ER | Collegium Pharmaceutical | Marketed |
| BELBUCA | Collegium Pharmaceutical | Marketed |